Literature DB >> 28404701

Diagnosis and management of psoriasis.

Whan B Kim1, Dana Jerome2, Jensen Yeung3.   

Abstract

OBJECTIVE: To provide primary care clinicians with an up-to-date and practical overview of the diagnosis and management of psoriasis. QUALITY OF EVIDENCE: PubMed, MEDLINE, EMBASE, and Cochrane databases were searched for relevant meta-analyses, randomized controlled trials, systematic reviews, and observational studies about the diagnosis and management of psoriasis. MAIN MESSAGE: Psoriasis is a chronic, multisystem inflammatory disease with predominantly skin and joint involvement. Beyond the physical dimensions of disease, psoriasis has an extensive emotional and psychosocial effect on patients, affecting social functioning and interpersonal relationships. As a disease of systemic inflammation, psoriasis is associated with multiple comorbidities, including cardiovascular disease and malignancy. The diagnosis is primarily clinical and a skin biopsy is seldom required. Depending on the severity of disease, appropriate treatment can be initiated. For mild to moderate disease, first-line treatment involves topical therapies including corticosteroids, vitamin D3 analogues, and combination products. These topical treatments are efficacious and can be safely initiated and prescribed by primary care physicians. Patients with more severe and refractory symptoms might require further evaluation by a dermatologist for systemic therapy.
CONCLUSION: Many patients with psoriasis seek initial evaluation and treatment from their primary care providers. Recognition of psoriasis, as well as its associated medical and psychiatric comorbidities, would facilitate timely diagnosis and appropriate management with effective and safe topical therapies and other medical and psychological interventions, as needed. More severe and refractory cases might warrant referral to a dermatologist for further evaluation and possible systemic therapy. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28404701      PMCID: PMC5389757     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  37 in total

Review 1.  Acitretin combination therapy.

Authors:  H H Roenigk
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

2.  New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care.

Authors:  S R Feldman; A B Fleischer; J Z Cooper
Journal:  Int J Dermatol       Date:  2000-01       Impact factor: 2.736

Review 3.  Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology.

Authors:  Philip Mease
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 4.  Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis.

Authors:  M Lebwohl; L Drake; A Menter; J Koo; A B Gottlieb; M Zanolli; M Young; P McClelland
Journal:  J Am Acad Dermatol       Date:  2001-10       Impact factor: 11.527

5.  Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis.

Authors:  K Kragballe; P C M van de Kerkhof
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-01       Impact factor: 6.166

6.  Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis: A Bayesian Network Meta-analysis.

Authors:  Vincent W Lin; Sarah Ringold; Emily Beth Devine
Journal:  Arch Dermatol       Date:  2012-12

7.  Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

Authors:  Alan Menter; Neil J Korman; Craig A Elmets; Steven R Feldman; Joel M Gelfand; Kenneth B Gordon; Alice B Gottlieb; John Y M Koo; Mark Lebwohl; Henry W Lim; Abby S Van Voorhees; Karl R Beutner; Reva Bhushan
Journal:  J Am Acad Dermatol       Date:  2009-06-03       Impact factor: 11.527

8.  Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses.

Authors:  Abrar A Qureshi; Hyon K Choi; Arathi R Setty; Gary C Curhan
Journal:  Arch Dermatol       Date:  2009-04

9.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-10-01       Impact factor: 7.580

Review 10.  Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.

Authors:  Philip J Mease; April W Armstrong
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

View more
  70 in total

Review 1.  Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review.

Authors:  Martyna Zagórska-Dziok; Marcin Sobczak
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

Review 2.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

Review 3.  Pain Management in Painful Psoriasis and Psoriatic Arthropathy: Challenging and Intricately Intertwined Issues Involving Several Systems.

Authors:  Vijay Kodumudi; Kanishka Rajput
Journal:  Curr Pain Headache Rep       Date:  2021-04-06

Review 4.  A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine.

Authors:  Sonia Pandey; Purnima Tripathi; Arti Gupta; Jitendra Singh Yadav
Journal:  Drug Deliv Transl Res       Date:  2021-09-22       Impact factor: 4.617

5.  Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies.

Authors:  Saumya Choudhary; Rachana Patel; Dibyabhaba Pradhan; Ravi Deval; Harpreet Singh; George Thomas; Arun Kumar Jain
Journal:  3 Biotech       Date:  2020-02-07       Impact factor: 2.406

Review 6.  Psoriasis and Gut Microbiome-Current State of Art.

Authors:  Karina Polak; Beata Bergler-Czop; Michał Szczepanek; Kamila Wojciechowska; Aleksandra Frątczak; Norbert Kiss
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis.

Authors:  April W Armstrong; Ahmed M Soliman; Keith A Betts; Yan Wang; Yawen Gao; Luis Puig; Matthias Augustin
Journal:  Dermatol Ther (Heidelb)       Date:  2021-03-31

Review 8.  Polymeric Gels and Their Application in the Treatment of Psoriasis Vulgaris: A Review.

Authors:  Agnieszka Kulawik-Pióro; Małgorzata Miastkowska
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

9.  A Case Report of Antibiotic-Induced Aseptic Meningitis in Psoriasis.

Authors:  Andrew Wai Kei Ko; Arash Ghaffari-Rafi; Alvin Chan; William B Harris; Arcelita Imasa; Kore Kai Liow; Jason Viereck
Journal:  Hawaii J Health Soc Welf       Date:  2021-06

10.  Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study.

Authors:  Giovanna Malara; Cristina Politi; Caterina Trifirò; Chiara Verduci; Graziella D'Arrigo; Alessandra Testa; Giovanni Tripepi
Journal:  Acta Derm Venereol       Date:  2021-09-15       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.